An observational study in Pseudoarthrosis of Bone, sponsored by Hospices Civils de Lyon. Completed at 1 site in France. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2019-02-18.
Sponsored by Hospices Civils de Lyon · Observational
Description of septic pseudarthrosis with chirurgical treatment in two steps (first step : Implementation of cement, second step : bone reconstruction, with or without device)
41 studies on the registry are indexed under Pseudarthrosis; 7 are open to participants now.
This study's enrollment of 20 is below the median of 60 across 16 observational studies indexed under Pseudarthrosis.
Browse Pseudarthrosis studies →Hospices Civils de Lyon is the lead sponsor of 1,866 studies on the registry; 448 are open to participants now.
Counted across the registry records on this site, refreshed daily.
: patients having septic pseudarthrosis managed with 2 steps chirurgical treatment
Exclusion Criteria:
-
chirurgical and medical treatment
Other: Description of treatment of septic pseudarthrosis
description of chirurgical 2 steps management of septic pseudarthrosis
Description of treatment of septic pseudarthrosis : chirurgical treatment - rate of use of this type of chirurgical treatment among patients with septic pseudarthrosis
Description of treatment of septic pseudarthrosis : chirurgical treatment
Time frame: Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption)
Description of treatment of septic pseudarthrosis : medical treatment - duration of treatment in patients having sepstic pseudarthrosis
Description of treatment of septic pseudarthrosis : medical treatment
Time frame: Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption)
Treatment failure : rate of failure with this 2 times chirurgical treatment
Treatment failure is defined by local clinical and/or microbiological relapse; and/or need for additional surgery; death of septic origin
Time frame: Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption)
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.